Parallel Advisors’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414 | Hold |
200
| – | – | ﹤0.01% | 3301 |
|
|
2025
Q1 | $440 | Hold |
200
| – | – | ﹤0.01% | 3239 |
|
|
2024
Q4 | $306 | Hold |
200
| – | – | ﹤0.01% | 3292 |
|
|
2024
Q3 | $398 | Hold |
200
| – | – | ﹤0.01% | 3198 |
|
|
2024
Q2 | $700 | Hold |
200
| – | – | ﹤0.01% | 3017 |
|
|
2024
Q1 | $554 | Hold |
200
| – | – | ﹤0.01% | 3036 |
|
|
2023
Q4 | $340 | Hold |
200
| – | – | ﹤0.01% | 3110 |
|
|
2023
Q3 | $206 | Sell |
200
-623
| -76% | -$642 | ﹤0.01% | 3227 |
|
|
2023
Q2 | $955 | Hold |
823
| – | – | ﹤0.01% | 2950 |
|
|
2023
Q1 | $1.24K | Buy |
823
+623
| +312% | +$941 | ﹤0.01% | 2903 |
|
|
2022
Q4 | $500 | Hold |
200
| – | – | ﹤0.01% | 3029 |
|
|
2022
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 2898 |
|
|
2022
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 2761 |
|
|
2022
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 2748 |
|
|
2021
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 2689 |
|
|
2021
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 2669 |
|
|
2021
Q2 | $3K | Hold |
200
| – | – | ﹤0.01% | 2433 |
|
|
2021
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 2350 |
|
|
2020
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 2078 |
|
|
2020
Q3 | $3K | Sell |
200
-122
| -38% | -$1.83K | ﹤0.01% | 2165 |
|
|
2020
Q2 | $4K | Buy |
322
+122
| +61% | +$1.52K | ﹤0.01% | 2004 |
|
|
2020
Q1 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 2127 |
|
|
2019
Q2 | – | Sell |
-1,685
| Closed | -$41K | – | 2352 |
|
|
2019
Q1 | $41K | Buy |
1,685
+1,200
| +247% | +$29.2K | ﹤0.01% | 918 |
|
|
2018
Q4 | $12K | Buy |
+485
| New | +$12K | ﹤0.01% | 1244 |
|
|
2017
Q3 | – | Sell |
-250
| Closed | -$4K | – | 2150 |
|
|
2017
Q2 | $4K | Hold |
250
| – | – | ﹤0.01% | 1670 |
|
|
2017
Q1 | $4K | Hold |
250
| – | – | ﹤0.01% | 1577 |
|
|
2016
Q4 | $3K | Buy |
+250
| New | +$3K | ﹤0.01% | 1527 |
|